ATTRACT

ATTRACT

Anti-TNF Trial in Rheumatoid Arthritis with cA2 (Chimeric monoclonal antibody) infliximab Treatment. A trial comparing the effects of humanised anti-TNF cA2 (infliximab/Remicade) + methotrexate (MTX) to MTX alone on the progression of rheumatoid arthritis.
Conclusions It works; infliximab patients had retardation or arrest of their rheumatoid arthritis; and improvement (in 39% to 54% of patients) of joint space narrowing and bone erosion, vs progressive damage in control patients treated with MTX alone.

Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

ATTRACT

Rheumatology A clinical trial–Anti-TNF Trial in Rheumatoid Arthritis with CA2 Treatment–which evaluated the effects of humanized anti-TNF–cA2–treatment on Pts with RA. See Remicade^®, Rheumatoid arthritis.

McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.